Sotera Health Company carries a market capitalization of 5.39B, placing it among publicly traded companies globally. Its enterprise value stands at 6.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.39B |
| Enterprise Value | 6.98B |
Sotera Health Company currently has 285.36M shares outstanding.
| Shares Outstanding | 285.36M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Sotera Health Company trades at a trailing price-to-earnings ratio of 30.92. The price-to-sales ratio is 4.16, and the price-to-book ratio stands at 7.61.
| PE Ratio | 30.92 |
| PS Ratio | 4.16 |
| PB Ratio | 7.61 |
| P/TBV Ratio | -7.28 |
| P/FCF Ratio | 10.82 |
| P/OCF Ratio | 17.30 |
On an enterprise value basis, Sotera Health Company trades at an EV/EBITDA multiple of 13.31 and an EV/FCF ratio of 12.45. The EV/Sales ratio of 5.74 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.48 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.74 |
| EV / EBITDA | 13.31 |
| EV / EBIT | 17.48 |
| EV / FCF | 12.45 |
Sotera Health Company maintains a current ratio of 2.80, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 340.73, indicating elevated leverage, while an interest coverage ratio of 3.66 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.80 |
| Quick Ratio | 2.40 |
| Debt / Equity | 340.73 |
| Debt / EBITDA | 4.33 |
| Interest Coverage | 3.66 |
Sotera Health Company posts a return on equity of 27.78 and a return on invested capital of 8.51.
| Return on Equity (ROE) | 27.78 |
| Return on Assets (ROA) | 5.01 |
| Return on Invested Capital (ROIC) | 8.51 |
| Return on Capital Employed (ROCE) | 8.70 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 9.42 |
Over the trailing twelve months, Sotera Health Company has paid 100.62M in income taxes, reflecting an effective tax rate of 38.10.
| Income Tax | 100.62M |
| Effective Tax Rate | 38.10 |
Sotera Health Company's stock has gained approximately 21.93548% over the past 52 weeks. The 50-day moving average sits at 18.31, while the 200-day moving average is 16.79.
| Beta (5Y) | N/A |
| 52-Week Price Change | 21.93548% |
| 50-Day Moving Average | 18.31 |
| 200-Day Moving Average | 16.79 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Sotera Health Company generated 1.22B in revenue and converted that into 163.48M in net income, yielding earnings per share of 0.57. EBITDA reached 524.28M, while operating income came in at 399.18M.
| Revenue | 1.22B |
| Gross Profit | 668.51M |
| Operating Income | 399.18M |
| Pretax Income | 264.10M |
| Net Income | 163.48M |
| EBITDA | 524.28M |
| EBIT | 399.18M |
| Earnings Per Share (EPS) | 0.57 |
Sotera Health Company holds 356.72M in cash and equivalents against 2.27B in total debt, resulting in a net debt position of 1.78B. Total book value stands at 665.65M, with working capital of 415.22M providing operational flexibility.
| Cash & Cash Equivalents | 356.72M |
| Total Debt | 2.27B |
| Net Debt | 1.78B |
| Equity (Book Value) | 665.65M |
| Book Value Per Share | 2.33 |
| Working Capital | 415.22M |
Sotera Health Company produced 292.19M in operating cash flow over the past twelve months. After subtracting -179.49M in capital expenditures, free cash flow totaled 112.70M - equivalent to 0.40 per share.
| Operating Cash Flow | 292.19M |
| Capital Expenditures | -179.49M |
| Free Cash Flow | 112.70M |
| FCF Per Share | 0.40 |
Sotera Health Company operates with a gross margin of 54.97, reflecting its pricing power and cost economics. The operating margin of 32.82 and net profit margin of 13.44 provide insight into operational efficiency.
| Gross Margin | 54.97 |
| Operating Margin | 32.82 |
| Pretax Margin | 21.72 |
| Profit Margin | 13.44 |
| EBITDA Margin | 43.11 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.99 |
| FCF Yield | 9.24 |
Sotera Health Company posts an Altman Z-Score of 2.38, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.38 |